It almost always happens at home, almost always at night, and almost always to a dog that was perfectly fine ten minutes ago. The dog stiffens, falls on his side, paddles his legs, may urinate or salivate heavily, and stares without seeing. It lasts a minute or two — though it feels like twenty — and then he is up again, dazed, bumping into furniture, ravenously thirsty. The owner records it on a phone in shaking hands and books an emergency appointment. For perhaps three quarters of those dogs, the eventual diagnosis is idiopathic epilepsy: a chronic, presumed-genetic brain disease that is the single most common neurological disorder in dogs.

"Idiopathic" simply means we cannot identify a structural cause. In 2015 the International Veterinary Epilepsy Task Force (IVETF) — a group of veterinary neurologists from across Europe and North America — published a set of consensus statements that, for the first time, gave veterinarians a standardized way to define, classify, diagnose, and treat the disease. A decade on, those documents remain the reference standard for canine epilepsy care worldwide.

How Common Is It, and Which Dogs Are at Risk

Epilepsy affects roughly 0.6–0.75% of the general dog population, with some breed-specific surveys pushing prevalence as high as 5%. An inherited basis has now been established in more than 25 breeds, and the disease is reported in over 35. The classic high-risk lineups include:

The typical age of onset is between 6 months and 6 years — a key IVETF criterion. A dog whose first seizure occurs before 6 months or after 6 years is statistically more likely to have a structural cause (a brain tumor, inflammatory disease, or congenital malformation) than primary idiopathic epilepsy.

What a Seizure Actually Looks Like

Most epileptic dogs have generalized tonic–clonic seizures: loss of consciousness, full-body stiffening (the tonic phase), then rhythmic paddling or jerking (the clonic phase). Salivation, urination, defecation, and vocalizing are common. A small but important fraction have focal seizures instead — repetitive facial twitching, a fixed stare, "fly biting" at thin air, or one-sided limb movements — and these are easy to miss or mistake for a behavioral tic.

Every seizure has three phases that owners can learn to recognize. The pre-ictal phase may last seconds to hours: restlessness, clinginess, hiding, or pacing. The ictal phase is the seizure itself, typically 30 seconds to 2 minutes. The post-ictal phase — confusion, blindness, ataxia, excessive hunger or thirst — can last minutes to days and is sometimes more distressing for owners than the seizure itself.

Two patterns turn epilepsy into a medical emergency. Cluster seizures means two or more seizures within 24 hours. Status epilepticus means a single seizure lasting longer than 5 minutes, or repeated seizures without full recovery in between. Both demand emergency veterinary care: prolonged seizing causes hyperthermia, lactic acidosis, and irreversible brain injury.

The IVETF Diagnostic Tiers

Because idiopathic epilepsy is a diagnosis of exclusion, the IVETF defined three tiers of diagnostic confidence rather than a single yes/no test.

Tier I is the minimum: a dog between 6 months and 6 years of age, two or more unprovoked seizures at least 24 hours apart, a normal neurological exam between seizures, and unremarkable blood and urine work (including bile acids to rule out hepatic encephalopathy). Most dogs are diagnosed at this tier in general practice.

Tier II adds fasting and post-prandial bile acids, a normal brain MRI, and normal cerebrospinal fluid analysis — i.e., it actively rules out structural disease. This is the standard of care if seizures begin outside the typical age window, if the neurological exam is abnormal between seizures, if seizures are focal, or if the dog fails to respond to first-line therapy.

Tier III additionally requires abnormal electroencephalography (EEG) consistent with epileptic activity. Because canine EEG is technically demanding and largely confined to research centers, this tier is reached almost only in academic settings.

When to Start Treatment

Not every dog with a single seizure needs lifelong medication. The 2016 American College of Veterinary Internal Medicine (ACVIM) consensus statement on seizure management recommends starting an antiseizure drug when any of the following is true: two or more seizures within a six-month period; cluster seizures or status epilepticus; severe or prolonged post-ictal signs; or evidence that seizure frequency or severity is increasing. A single isolated seizure in an otherwise healthy young adult dog is usually not treated; the dog is monitored and the conversation revisited if a second seizure occurs.

The realistic treatment goal is not zero seizures. The widely accepted benchmark is a ≥50% reduction in seizure frequency, ideally with no severe side effects. By that standard, most dogs do well.

First-Line Antiseizure Drugs

A 2014 systematic review and the IVETF treatment consensus identified four medications with the strongest evidence base in dogs.

Phenobarbital is the historical workhorse and the most widely prescribed first-line drug. Studies report a ≥50% seizure reduction in roughly 60–93% of treated dogs. Side effects include sedation, polydipsia/polyuria, polyphagia, and — in a small minority of dogs at higher doses or longer durations — hepatotoxicity, which is why blood levels and liver enzymes are checked at regular intervals.

Imepitoin (Pexion) is a low-affinity partial agonist at the GABAA benzodiazepine site, licensed in Europe and Australia for canine idiopathic epilepsy. It has a much friendlier side-effect profile than phenobarbital, no required liver-enzyme monitoring, and good evidence of efficacy in dogs with non-cluster generalized seizures. It is generally not effective for severe or refractory cases.

Potassium bromide is the oldest antiseizure drug in veterinary medicine — older, in fact, than every drug used in human epileptology — and remains widely used either as add-on therapy or as monotherapy in dogs with hepatic concerns. It has a long half-life and reaches steady state slowly (weeks to months).

Levetiracetam (Keppra) has become a popular add-on because it is well tolerated and excreted by the kidneys rather than metabolized by the liver. It is the most commonly used drug for acute control of cluster seizures at home (the "pulse" protocol).

Despite all of this, 20–35% of epileptic dogs develop drug-resistant epilepsy, defined as failure to achieve adequate seizure control on two appropriately dosed antiseizure drugs. Those dogs benefit from referral to a board-certified neurologist.

The Diet Worth Knowing About

A 2015 randomized, placebo-controlled crossover trial led by Tsz Hong Law and colleagues at the Royal Veterinary College tested a diet enriched with medium-chain triglycerides (MCTs) in 21 dogs with drug-resistant idiopathic epilepsy. Dogs eating the MCT diet had significantly fewer seizures than dogs on the matched control diet, and 3 of the 21 became seizure-free during the MCT phase. The commercial product (Purina Pro Plan NeuroCare in many markets) is now a reasonable add-on for dogs whose seizures are not controlled by drugs alone. It is not a substitute for medication.

What Owners Can Actually Do

The single most useful tool is a seizure diary — date, time, length, type, suspected triggers, post-ictal duration. Patterns that look invisible week to week become obvious over months, and they are what drives every treatment decision. Owners are also taught to never put a hand in the dog's mouth during a seizure (dogs do not swallow their tongues, and they do bite reflexively), to time the seizure with a phone, to move furniture and stairs out of the way, and to seek emergency care if a single seizure passes the 5-minute mark or if a second seizure occurs without full recovery.

Most veterinary neurologists also prescribe an at-home rescue protocol — usually intranasal or rectal diazepam, or oral pulse-dose levetiracetam — to be given after a first seizure in a cluster, to head off the second.

Prognosis

The honest summary is that idiopathic epilepsy is a chronic disease that is usually well-managed, sometimes poorly managed, and occasionally heartbreaking. Most well-controlled dogs live a normal lifespan with normal quality of life. A meaningful minority — roughly one in five to one in three — never achieves satisfactory control. Survival is shorter in dogs whose seizures begin before one year of age, in dogs with cluster seizures, and in certain high-risk breeds. But the majority of dogs given a seizure diary, a steady drug regimen, and a calm household will spend most of their years between seizures rather than fighting them — and that is the realistic, evidence-based goal.